Search Results

Showing results 7071 - 7080 for medical records

Neuberger Berman Lung Cancer Research Center | Page 2 | Cardiothoracic Surgery

...The Clinical Trials and Healthcare Outcomes Center prospectively records the outcomes of these patients...

https://ctsurgery.weillcornell.org/research/neuberger-berman-lung-cancer-research-center?page=1

Epigenomics: Recording the past & predicting the future | Research | Weill Cornell Medicine

...Faculty Directory Achievements Calendar Graduate Education Diversity in Research Epigenomics: Recording...

https://research.weill.cornell.edu/about-us/news-updates/epigenomics-recording-past-predicting-future

QIA Celebrates Class of 2020 with Impressive Array of Projects: Focus on Collaboration | Weill Department of Medicine

...A recording of the full event and poster handbook is available by emailing qia-dom@med.cornell.edu....

https://medicine.weill.cornell.edu/news/qia-celebrates-class-2020-impressive-array-projects-focus-collaboration

Past Events | Page 10 | Enterprise Innovation

...Session recordings are NOT distributed afterward....

https://innovation.weill.cornell.edu/news-and-events/past-events?page=9

Chemotherapy Use in the Months Before Death and Estimated Costs of Care in the Last Week of Life. | Population Health Sciences

...Data included medical records, patient baseline surveys (median four months before death), and postmortem...

https://phs.weill.cornell.edu/chemotherapy-use-months-death-and-estimated-costs-care-last-week-life

News and Updates | Richard T. Silver MD Myeloproliferative Neoplasms Center

...Records Make a Difference Email List Richard T....

https://silvermpncenter.weill.cornell.edu/news-and-updates

Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study. | Richard T. Silver MD Myeloproliferative Neoplasms Center

...Records Make a Difference Email List Richard T....

https://silvermpncenter.weill.cornell.edu/janus-kinase-2-inhibitor-fedratinib-patients-myelofibrosis-previously-treated-ruxolitinib-jakarta-2

Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States. | Richard T. Silver MD Myeloproliferative Neoplasms Center

...Records Make a Difference Email List Richard T....

https://silvermpncenter.weill.cornell.edu/cost-effectiveness-tyrosine-kinase-inhibitor-treatment-strategies-chronic-myeloid-leukemia-chronic

Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful Engraftment. | Richard T. Silver MD Myeloproliferative Neoplasms Center

...Records Make a Difference Email List Richard T....

https://silvermpncenter.weill.cornell.edu/allogeneic-transplantation-patients-advanced-myelofibrosis-splenomegaly-and-high-serum-ldh-are

Conditions | Richard T. Silver MD Myeloproliferative Neoplasms Center

...Records Make a Difference Email List Richard T....

https://silvermpncenter.weill.cornell.edu/patients/conditions

Showing results 7071 - 7080 for medical records